Catherine Lai

3.1k total citations · 1 hit paper
77 papers, 1.3k citations indexed

About

Catherine Lai is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Catherine Lai has authored 77 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Hematology, 25 papers in Oncology and 15 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Catherine Lai's work include Acute Myeloid Leukemia Research (33 papers), Lymphoma Diagnosis and Treatment (12 papers) and Hematopoietic Stem Cell Transplantation (9 papers). Catherine Lai is often cited by papers focused on Acute Myeloid Leukemia Research (33 papers), Lymphoma Diagnosis and Treatment (12 papers) and Hematopoietic Stem Cell Transplantation (9 papers). Catherine Lai collaborates with scholars based in United States, United Kingdom and Japan. Catherine Lai's co-authors include Rahul S. Bhansali, Keith W. Pratz, Christopher S. Hourigan, Kelly J. Norsworthy, Kieron Dunleavy, Wyndham H. Wilson, Seth M. Steinberg, Mark Roschewski, Laura W. Dillon and Elaine S. Jaffe and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Catherine Lai

68 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recent advances in targeted therapies in acute myeloid leukemia

2023 137 citations Catherine Lai et al. Journal of Hematology & Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Catherine Lai United States	16	492	399	361	316	311	77	1.3k
Claudio Cerchione Italy	20	472 1.0×	574 1.4×	585 1.6×	167 0.5×	121 0.4×	123	1.3k
Seongseok Yun United States	18	344 0.7×	306 0.8×	464 1.3×	206 0.7×	76 0.2×	79	1.1k
E.J. Shpall United States	19	612 1.2×	254 0.6×	564 1.6×	112 0.4×	209 0.7×	48	1.4k
Mojtaba Akhtari United States	19	444 0.9×	290 0.7×	394 1.1×	105 0.3×	75 0.2×	77	1.2k
Anna Butturini United States	17	432 0.9×	258 0.6×	301 0.8×	86 0.3×	120 0.4×	48	1.1k
Shahzad Raza United States	19	257 0.5×	517 1.3×	338 0.9×	143 0.5×	244 0.8×	120	1.4k
Jan Philipp Bewersdorf United States	26	1.1k 2.3×	707 1.8×	372 1.0×	72 0.2×	97 0.3×	137	1.8k
Pasquale Iacopino Italy	21	774 1.6×	255 0.6×	405 1.1×	210 0.7×	55 0.2×	72	1.3k
Christian Bogner Germany	19	225 0.5×	524 1.3×	246 0.7×	229 0.7×	44 0.1×	28	1.1k
Hiroshi Moritake Japan	17	301 0.6×	301 0.8×	181 0.5×	69 0.2×	78 0.3×	80	874

Countries citing papers authored by Catherine Lai

Since Specialization

Citations

This map shows the geographic impact of Catherine Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Lai more than expected).

Fields of papers citing papers by Catherine Lai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Lai. The network helps show where Catherine Lai may publish in the future.

Co-authorship network of co-authors of Catherine Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Lai. A scholar is included among the top collaborators of Catherine Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Lai. Catherine Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cortés, J.‐C., Carlos H. Barrios, Adam Brufsky, et al.. (2025). LBA20 Primary results from ASCENT-03: A randomized phase III study of sacituzumab govitecan (SG) vs chemotherapy (chemo) in patients (pts) with previously untreated advanced triple-negative breast cancer (TNBC) who are unable to receive PD-(L)1 inhibitors (PD-[L]1i). Annals of Oncology. 36. S1565–S1566.

Solomon, Scott R., Bayard L. Powell, Catherine Lai, et al.. (2024). CPX-351 Pharmacokinetics and Safety in Adults with Hematologic Malignancies and Renal Function Impairment: Phase 1 Trial. Cancers. 16(5). 915–915.

Lai, Catherine, et al.. (2024). Hierarchical Intonation Modelling for Speech Synthesis using Legendre Polynomial Coefficients. Edinburgh Research Explorer. 1030–1034. 2 indexed citations

Chan, Bryan, et al.. (2024). Influence of Income, Education, and Medicaid Expansion on Palliative Care in Acute Myeloid Leukemia Using the National Cancer Database. Journal of Pain and Symptom Management. 67(4). e341–e346. 1 indexed citations

Lai, Catherine, et al.. (2024). Breaking down frailty: Assessing vulnerability in acute myeloid leukemia. Blood Reviews. 68. 101224–101224. 3 indexed citations

Taylor, Allison, et al.. (2024). Survival Outcomes in Older Adult Acute Lymphoblastic Leukemia Patients Analyzed by Facility Volume and Type: A National Cancer Database Analysis. Cancer Reports. 7(8). e2162–e2162. 1 indexed citations

Williams, Kirsten M., Nancy Gillis, Kelly L. Bolton, et al.. (2023). Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 30(3). 255–267. 10 indexed citations

Geng, Xue, et al.. (2023). Systematic review and meta‐analysis: Prognostic impact of time from diagnosis to treatment in patients with acute myeloid leukemia. Cancer. 129(19). 2975–2985. 4 indexed citations

Lai, Catherine, et al.. (2023). Optimizing the Integration of Genetic Testing in AML Care in Community Practice: Insights from a Quality Improvement Initiative. Blood. 142(Supplement 1). 7277–7277.

10.

Taylor, Allison, et al.. (2023). Facility type and volume impact outcomes in acute myeloid leukemia—a National Cancer Database Study. 7. 2–2. 4 indexed citations

11.

Kalinsky, Kevin, Laura M. Spring, Clinton Yam, et al.. (2023). Real-world outcomes in patients (pts) with metastatic triple-negative breast cancer (mTNBC) treated with sacituzumab govitecan (SG) in 2L+ in the United States (US).. Journal of Clinical Oncology. 41(16_suppl). e18879–e18879. 2 indexed citations

12.

Marks, Jennifer A., et al.. (2023). TP53 in AML and MDS: The new (old) kid on the block. Blood Reviews. 60. 101055–101055. 10 indexed citations

13.

Cook, Michael, Katherine White, Sameer Desale, et al.. (2021). Thrombotic and Clinical Outcomes in Patients with Hematologic Malignancy and COVID-19. Clinical Lymphoma Myeloma & Leukemia. 22(7). e452–e458. 2 indexed citations

14.

Broome, Catherine M., et al.. (2020). Complete remission of aggressive T-cell LGL leukemia with pentostatin therapy: first case report. PubMed. 7. 24–24.

15.

Lai, Catherine, et al.. (2019). Recent drug approvals for acute myeloid leukemia. Journal of Hematology & Oncology. 12(1). 100–100. 105 indexed citations

16.

Lai, Catherine, et al.. (2019). <p>The Evolving Role of Brentuximab Vedotin in Classical Hodgkin Lymphoma</p>. PubMed. Volume 9. 63–71. 10 indexed citations

17.

Oetjen, Karolyn A., Katherine E. Lindblad, Meghali Goswami, et al.. (2018). Human bone marrow assessment by single-cell RNA sequencing, mass cytometry, and flow cytometry. JCI Insight. 3(23). 119 indexed citations

18.

Percival, Mary‐Elizabeth M., Catherine Lai, Elihu H. Estey, & Christopher S. Hourigan. (2017). Bone marrow evaluation for diagnosis and monitoring of acute myeloid leukemia. Blood Reviews. 31(4). 185–192. 78 indexed citations

19.

Ito, Sawa, Jeffrey R. Strich, Maura Manion, et al.. (2017). Successful salvage chemotherapy and allogeneic transplantation of an acute myeloid leukemia patient with disseminated Fusarium solani infection. Leukemia Research Reports. 8. 4–6. 7 indexed citations

20.

Lai, Catherine & Kieron Dunleavy. (2013). NK/T-cell lymphomas in children. Best Practice & Research Clinical Haematology. 26(1). 33–41. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact